SCHEMBL9022900

SCHEMBL9022900

O=C(O)c1cccn1Cc1cccs1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
TSHR P16473 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.43
CYP2C9 P11712 1/20 0.41
ALDH1A1 P00352 1/20 0.40
HPGD P15428 2/20 0.40
PRSS1 P07477 1/20 0.40
TMPRSS15 P98073 1/20 0.40
POLB P06746 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
HTT P42858 1/20 0.39
EPHX2 P34913 2/20 0.39
DAO P14920 1/20 0.39
LMNA P02545 1/20 0.39
DRD4 P21917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11326618 0.86 CYP2C19 (0.45) CYP2C19CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL27263178 0.76 DAO (0.40) ALDH1A1PRSS1TMPRSS15EPHX2DAO
SCHEMBL1607395 0.74 CNR2 (0.57) TSHRL3MBTL1ALDH1A1SMN1; SMN2EPHX2
SCHEMBL28420210 0.74 HSP90AA1 (0.45) CYP2C19TSHRL3MBTL1CYP2C9ALDH1A1
SCHEMBL9765614 0.73 EPHX2 (0.44) CYP2C19CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL24434943 0.72 KDM4E (0.49) CYP2C19CYP1A2CYP3A4CYP2C9SMN1; SMN2
SCHEMBL13120839 0.72 ALDH1A1 (0.41) TSHRL3MBTL1ALDH1A1HPGDHSD17B10
SCHEMBL11334754 0.72 ALDH1A1 (0.47) CYP2C19CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL7506763 0.72 PARP2 (0.43) CYP2C19CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL16347227 0.71 HTT (0.42) TSHRL3MBTL1ALDH1A1TDP1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0381141-B1 Novel aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions MERRELL DOW PHARMA (US) 1996-03-20 EP disclosed
CN-1022754-C Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds preparation method MERRELL DOW PHARMA (US) 1993-11-17 CN disclosed
US-5041554-A Replace steroids in treatment of inflammatory diseases MERRELL DOW PHARMACEUTICALS INC. (US) 1991-08-20 US disclosed
US-5039695-A Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions MERRELL DOW PHARMACEUTICALS INC. (US) 1991-08-13 US disclosed
CN-1044653-A The new aryl or the heteroaryl-I-alkyl-pyrroles-2-carboxylic acid that are used for the treatment of the pathological state of interleukin-I mediation MERRELL DOW PHARMA (US) 1990-08-15 CN disclosed